| Session Number | Presenter | Session | Presentation title | Time | Access |
|---|---|---|---|---|---|
| OP-1 | Amir Sharif | Oral Presentations | Hydrogen sulfide-based therapeutics for neurological conditions | 09:29 min | View Oral Presentation |
| OP-2 | Jendé Zijlmans | Oral Presentations | The role of cognitive and brain reserve in late-life depression | 09:41 min | View Oral Presentation |
| OP-3 | Sabah Rehman | Oral Presentations | Sex Differences in Delayed Cerebral Ischemia and Hydrocephalus after Aneurysmal Subarachnoid Haemorrhage (aSAH) - A Systematic Review and Meta-Analysis | 09:38 min | View Oral Presentation |
| OP-4 | Iago Perissinotti | Oral Presentations | Stroke etiologies in patients with COVID-19 | 19:18 min | View Oral Presentation |
| OP-5 | Thuy Nguyen | Oral Presentations | Facilitators to more timely treatment following aneurysmal subarachnoid hemorrhage in Southest Australia: results from na embedded mixed-methods study | 10:05 min | not available |
| OP-6 | Gita Soraya | Oral Presentations | Significant Association between the COMT, MAO-B, and DRD2 Polymorphisms with susceptibility to Motor Levodopa-induced Complications (MLIC) in | 15:38 min | View Oral Presentation |
| OP-7 | Abolfazl Avan | Oral Presentations | Age-, sex-, and risk-specific burden of neurological diseases in the North Africa and Middle East from 1990 to 2019: A systematic analysis of data from the Global Burden of Disease Study 2019 | 07:58 min | View Oral Presentation |
| OP-8 | Rita Krishnamurthi | Oral Presentations | Incidence of Stroke during the SARS-COV-2 Pandemic in New Zealand; Findings from ARCOS V, 2020 | 11:28 min | View Oral Presentation |
| Session Number | Presenter | Session | Presentation title | Time | Access |
|---|---|---|---|---|---|
| TS-1 | B. Norrving | Teaching Session: Meet the Editors | Meet the Immediate Past Editor of European Stroke Journal | 18:21 min | View Presentation |
| TS-2 | V. Feigin | Teaching Session: Meet the Editors | Meet the Editor of Neuroepidemiology | 20:11 min | View Presentation |
| P1-1 | E. Westenberg | Plenary Session #1: Neurological Disorders and COVID-19 | Global COVID-19 Neuro Research Coalition | 08:05 min | View Presentation |
| P1-2 | M. Giroud | Plenary Session #1: Neurological Disorders and COVID-19 | Telemedicine in Neurology since the COVID-19 pandemic | 12:08 min | View Presentation |
| P1-3 | D. Gandhi | Plenary Session #1: Neurological Disorders and COVID-19 | Neurological rehabilitation during the COVID-19 pandemic: What changes and what have we learnt | 27:44 min | View Presentation |
| P1-4 | T. Wijeratne | Plenary Session #1: Neurological Disorders and COVID-19 | Post Covid-19 Neurological Syndrome - Current Status and Future Perspective | 15:15 min | View Presentation |
| P1-5 | D. Gandhi | Plenary Session #1: Neurological Disorders and COVID-19 | Telerehabilitation for Neurological care- how real is the impact across the world- HIC versus LMIC perspectives | 29:25 min | View Presentation |
| P1-6 | V. Feigin | Plenary Session #1: Neurological Disorders and COVID-19 | Primary stroke and cardiovascular disease prevention strategy needs overhaul | 10:03 min | View Presentation |
| P2-1 | M. Chun | Plenary Session #2: Application of Risk Prediction (Scores) in Neurology | What the COVID-19 crisis is telling humanity | 11:04 min | View Presentation |
| P3-1 | G. Biessels | Plenary Session #3: Neuroepidemiology of Cognition | Lesion location helps to better understand cognitive impact of cerebrovascular disease: the Mata VCI Map consortium | 12:37 min | View Presentation |
| P3-2 | A. Brodtmann | Plenary Session #3: Neuroepidemiology of Cognition | Targeting exercise to prevent vascular cognitive impairment: the Post-Ischaemic Stroke Cardiovascular Exercise Study | 11:20 min | View Presentation |
| P3-3 | S. Pendlebury | Plenary Session #3: Neuroepidemiology of Cognition | Epidemiology and novel risk factors for dementia after stroke | 14:43 min | View Presentation |
| P3-4 | C. Chen | Plenary Session #3: Neuroepidemiology of Cognition | Preventing Vascular Cognitive Impairment with multiple lifestyle interventions | 15:09 min | View Presentation |
| P4-1 | E. Harshfield | Plenary Session #4: Genetics and Application of Mendelian Randomisation in Neurology | Metabolic associations with stroke, dementia, and imaging markers of cerebral small vessel disease: a comprehensive metabolomics study | 06:54 min | View Presentation |
| P4-2 | R. Akinyemi | Plenary Session #4: Genetics and Application of Mendelian Randomisation in Neurology | Genetics of stroke in Africans | 17:21 min | View Presentation |
| P5-1 | C. Ketzoian | Plenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases | Multiple Sclerosis Incidence in Uruguay: A Population-based Study | 14:28 min | View Presentation |
| P5-2 | J. Correale | Plenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases | Barriers to access and utilization of multiple sclerosis care services in Latin American patients | 20:53 min | View Presentation |
| P5-3 | C. Ketzoian | Plenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases | Poverty and neurological disorders in middle-low income countries | 15:39 min | View Presentation |
| P5-4 | F. Gracia | Plenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases | Prevalence and incidence surveys of MS in Latin America and the Caribbean | 18:11 min | View Presentation |
| P5-5 | J. Correale | Plenary Session #5: Epidemiology of Multiple Sclerosis, ALD and Demyelinating Diseases | Environmental factors involved in the development of MS in Latin America | 27:36 min | View Presentation |
| SP-1 | D. Wiebers | Special session: Brain Health, One Health and COVID-19 | Brain Health, One Health, COVID-19 and Our Collective Future | 16:55 min | View Presentation |
| SP-2 | M. Brainin | Special session: Brain Health, One Health and COVID-19 | 'Brain Health': vision or study endpoint? | 24:35 min | View Presentation |
| SP-3 | A. Winkler | Special session: Brain Health, One Health and COVID-19 | Advantages of a One Health Approach For Communicable and Noncommunicable Diseases | 27:34 min | View Presentation |
| SP-4 | A. Quain | Special session: Brain Health, One Health and COVID-19 | One Welfare, the Role of Health Professionals and Climate Change | 21:13 min | View Presentation |
| SP-5 | T. Wyatt | Special session: Brain Health, One Health and COVID-19 | Harm, Earth Juris Prudence and Human/Nonhuman Relationships | 20:12 min | View Presentation |
| SP-6 | K. Lee | Special session: Brain Health, One Health and COVID-19 | Rethinking Global Governance to Address Zoonotic Disease Risk | 26:37 min | View Presentation |
| P6-1 | M. Olaiya | Plenary Session #6: Statistical Techniques to Improve the Use of Observational Data | Propensity score techniques | 13:12 min | View Presentation |
| P6-2 | C. Riberholt | Plenary Session #6: Statistical Techniques to Improve the Use of Observational Data | Statistical considerations for reducing the risk of type I or II errors in systematic reviews and meta-analysis | 14:32 min | View Presentation |
| P6-3 | M. Kilkenny | Plenary Session #6: Statistical Techniques to Improve the Use of Observational Data | Target trial approach | 14:27 min | View Presentation |
| P6-4 | D. Cadilhac | Plenary Session #6: Statistical Techniques to Improve the Use of Observational Data | Patient reported outcomes for guiding clinical practice, comparing service performance, and clinical data interpretation | 15:07 min | View Presentation |
| P7-1 | J. Pandian | Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC | Artificial Intelligence in stroke epidemiology | 13:21 min | View Presentation |
| P7-2 | W. Wang | Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC | Epidemiology and community control of epilepsy in rural areas of China | 15:27 min | View Presentation |
| P7-3 | J. Chopra | Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC | Neuropsychological rehabilitation in low resource settings - Challenges and outcomes | 12:18 min | View Presentation |
| P7-4 | J. Pandian | Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC | Methodology for documentation of stroke deaths in LMICs: challenges and way forward | 12:48 min | View Presentation |
| P7-5 | D. Sun | Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC | Epidemiology of brain injury | 11:55 min | View Presentation |
| P7-6 | J. Pandian | Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC | How to integrate stroke implementation research in health care system of developing countries | 12:47 min | View Presentation |
| P7-7 | S. Ge | Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC | Epidemiology of stroke and TIA | 14:52 min | View Presentation |
| P7-8 | J. Chopra | Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC | Cognitive and psychological rehabilitation in psychogenic non-epileptic seizures versus generalized epilepsy | 11:42 min | View Presentation |
| P7-9 | A. Winkler | Plenary Session #7: Innovations in Epidemiology of Neurological Disorders in LMIC | Challenges and Opportunities of neurological research in sub-Saharan Africa | 12:57 min | View Presentation |
| S1-1 | M. Alt Murphy | Scientific Session 1: Stroke and Dementia | Upper limb sensorimotor assessment after stroke – recommendations and implementation | 17:14 min | View Presentation |
| S1-2 | P. Sachdev | Scientific Session 1: Stroke and Dementia | Cognition, function and prevalent dementia in Centenarians and Near-Centenarians: an individual participant data (IPD) meta-analysis of 18 studies | 16:11 min | View Presentation |
| S1-3 | D. Bennett | Scientific Session 1: Stroke and Dementia | MTHFR and risk of stroke, ischemic heart disease and major non-vascular diseases: a Mendelian randomization study of Chinese adults | 23:19 min | View Presentation |
| S1-4 | M. Alt Murphy | Scientific Session 1: Stroke and Dementia | Virtual Reality in stroke rehabilitation | 19:53 min | View Presentation |
| S1-5 | D. Bennett | Scientific Session 1: Stroke and Dementia | Causal associations of blood lipids with risk of ischaemic stroke and intracerebral haemorrhage | 20:48 min | View Presentation |
| S1-6 | R. Akinyemi | Scientific Session 1: Stroke and Dementia | The burden of stroke in Africa | 17:47 min | View Presentation |
| S1-7 | D. Gabriel | Scientific Session 1: Stroke and Dementia | Long-term prognosis of primary intracerebral hemorrhage in XXI century: hospital cohorts compared to population-based cohorts | 10:36 min | View Presentation |
| S2-1 | S. Martins | Scientific Session 2: Using Research to Change Stroke Policies | How to use registries and epidemiological data to change policies? | 15:18 min | View Presentation |
| S2-2 | Y. Béjot | Scientific Session 2: Using Research to Change Stroke Policies | Clinical profile gap between stroke patients included in therapeutic trials and those in real-life practice: an important issue to deal with | 14:04 min | View Presentation |
| S2-3 | O. Pontes Neto | Scientific Session 2: Using Research to Change Stroke Policies | How to translate clinical trials in national policies? | 15:23 min | View Presentation |
| S2-4 | S. Martins | Scientific Session 2: Using Research to Change Stroke Policies | The gaps and solutions for primary prevention across the globe - to show the gaps and what the countries are doing to improve | 14:15 min | View Presentation |
| S3-1 | M. Morris | Scientific Session 3: International Networks to Advance Neurological Science & Practice | The Power of Dance for Parkinson’s: Developing Global Networks | 14:52 min | View Presentation |
| S3-2 | C. Orellana | Scientific Session 3: International Networks to Advance Neurological Science & Practice | The Collaboration of Aphasia Trialists; standardizing assessments to measure aphasia rehabilitation | 09:32 min | View Presentation |
| S3-3 | R. Fox | Scientific Session 3: International Networks to Advance Neurological Science & Practice | Global Collaboration: Lessons from Multiple Sclerosis | 11:21 min | View Presentation |
| S3-4 | G. Verheyden | Scientific Session 3: International Networks to Advance Neurological Science & Practice | The International Stroke Recovery & Rehabilitation Alliance | 13:16 min | View Presentation |
| P8-1 | Y. Béjot | Plenary Session #8: Cognitive Impairment and Dementia | Stroke in patients with cognitive impairment | 13:57 min | View Presentation |
| P8-2 | R. Akinyemi | Plenary Session #8: Cognitive Impairment and Dementia | Epidemiology, profile and determinant of post - stroke vascular cognitive impairment | 18:52 min | View Presentation |
| P8-3 | O. Godefroy | Plenary Session #8: Cognitive Impairment and Dementia | Diagnosis and management of post-stroke cognitive impairment in clinical practice | 16:33 min | View Presentation |
| P8-4 | G. Logroscino | Plenary Session #8: Cognitive Impairment and Dementia | Frontiers: FTD Incidence in Europe | 10:53 min | View Presentation |
| P8-5 | S. Debette | Plenary Session #8: Cognitive Impairment and Dementia | Cerebral small vessel disease in patients with cognitive decline | 17:50 min | View Presentation |
| P8-6 | G. Logroscino | Plenary Session #8: Cognitive Impairment and Dementia | Cognitive Impairment and Hearing Loss | 16:40 min | View Presentation |
| P8-7 | D. Ding | Plenary Session #8: Cognitive Impairment and Dementia | Olfactory dysfunction and risk of cognitive decline among older adults | 20:05 min | View Presentation |
| P9-1 | T. Wijeratne | Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches | Headache in ED | 11:30 min | View Presentation |
| P9-2 | T. O´Brien | Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches | Sudden onset death in epilepsy (SUDEP): Can it be prevented? | 17:19 min | View Presentation |
| P9-3 | G. Logroscino | Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches | Psychotic and Behavioral Symptoms in neurodegenerative diseases | 14:42 min | View Presentation |
| P9-4 | J. Wanigasinghe | Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches | Epidemiology of epilepsy in the South East Asian region | 14:32 min | View Presentation |
| P9-5 | T. Wijeratne | Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches | The Success story of World Brain Day | 16:30 min | View Presentation |
| P9-6 | J. Hinman | Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches | Antecedent autoimmune conditions and amyotrophic lateral sclerosis | 12:48 min | View Presentation |
| P9-7 | E. Zimmer | Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches | New perspectives in research for Alzheimer Disease | 15:38 min | View Presentation |
| P9-8 | L. Nelson | Plenary Session #9: Epidemiology of Neurodegenerative Disorders, Epilepsy and Headaches | Diabetes, Diabetes Medications and the Risk of Developing ALS | 14:42 min | View Presentation |
| Session Number | Presenter | Session | Presentation title | Time | Access |
|---|---|---|---|---|---|
| T1-1 | D. Ding | Teaching Session #1: Basics of clinical neuroepidemiology (observational studies) | Aims, design and pitfalls of cross-sectional studies: Application of cross-sectional design in large-sampled multicentered population-based surveys | 18:55 min | View Session |
| T1-2 | X. Leng | Teaching Session #1: Basics of clinical neuroepidemiology (observational studies) | Writing a scientific paper and reporting an observational study | 21:22 min | View Session |
| T1-3 | Y. Pan | Teaching Session #1: Basics of clinical neuroepidemiology (observational studies) | Aims, design and pitfalls of cohort studies | 12:38 min | View Session |
| T2-1 | D. Bennett | Teaching Session #2: Basics of clinical epidemiology | Basics of biostatistics | 24:17 min | View Session |
| T2-2 | G. Logroscino | Teaching Session #2: Basics of clinical epidemiology | Type, design and pitfalls of rcts and meta-analysis | 22:45 min | View Session |
| T2-3 | D. Bennett | Teaching Session #2: Basics of clinical epidemiology | Guidelines for reporting neuroepidemiological studies | 18:27 min | View Session |
| T3-1 | D. Bennett | Teaching Session #3: Basics of clinical epidemiology (continued) | Strengths and limitations of statistical analyses | 28:20 min | View Session |
| T3-2 | G. Logroscino | Teaching Session #3: Basics of clinical epidemiology (continued) | Studies and methods for descriptive epidemiology of rare neurodegenerative diseases in population studies | 18:59 min | View Session |
| ME-1 | B. Norrving | Meet the Editors | Publishing your manuscript: My best advice | 28:10 min | View Session |
| ME-2 | V. Feigin | Meet the Editors | Neuroepidemiology: Hints for publication | 29:16 min | View Session |
| P1-W | V. Feigin | Global impact of COVID | Welcome Message from the Chair | 03:21 min | View Session |
| P1-1 | D. Wiebers | Global impact of COVID | What the COVID-19 crisis is telling humanity (keynote lecture) | 15:18 min | View Session |
| P1-2 | E. Beghi | Global impact of COVID | Impact of COVID-19 on neurological disorders | 08:03 min | View Session |
| P1-3 | L. Liu | Global impact of COVID | Impact of COVID-19 on stroke care in China | 11:00 min | View Session |
| P2-1 | M. Owolabi | Stroke prevention and policy implications | The Lancet Neurology Commission on stroke: Evidence-based pragmatic solution to reduce the global burden of stroke (keynote lecture) | 11:07 min | View Session |
| P2-2 | G. Mensah | Stroke prevention and policy implications | Data science advances in the global prevention and treatment of stroke | 11:29 min | View Session |
| P2-3 | B. Norrving | Stroke prevention and policy implications | Using stroke statistics for policy purposes - challenges and opportunities | 10:16 min | View Session |
| P2-4 | V. Feigin | Stroke prevention and policy implications | Practical solution for motivational mass stroke prevention | 10:25 min | View Session |
| P2-5 | A. Towfighi | Stroke prevention and policy implications | From evidence to practice: What are we doing wrong? | 10:21 min | View Session |
| P3-1 | R. Krishnamurthi | Updates on and breaking news in clinical trials on stroke and dementia | Health & Wellness Coaching for primary stroke prevention: PREVENTS trial (keynote lecture) | 12:58 min | View Session |
| P3-2 | Y. Teuschl | Updates on and breaking news in clinical trials on stroke and dementia | The effects of the polypill in primary stroke prevention | 09:47 min | View Session |
| P3-3 | S. Davis | Updates on and breaking news in clinical trials on stroke and dementia | Endovascular thrombectomy - the challenges | 10:33 min | View Session |
| P3-4 | M. Brainin | Updates on and breaking news in clinical trials on stroke and dementia | Cognitive post-stroke disturbance (keynote lecture) | 16:00 min | View Session |
| P3-5 | J. Pandian | Updates on and breaking news in clinical trials on stroke and dementia | Community health workers for stroke prevention. What is the evidence? | 13:38 min | View Session |
| P3-6 | P. Sachdev | Updates on and breaking news in clinical trials on stroke and dementia | New consortia for studying dementia (COSMIC, STROKOG, and ICC) (keynote lecture) | 14:17 min | View Session |
| P3-7 | A. Ikram | Updates on and breaking news in clinical trials on stroke and dementia | Updates on dementia incidence, prevalence and risk factors in Europe | 14:40 min | View Session |
| P3-8 | R. Azarpazhooh | Updates on and breaking news in clinical trials on stroke and dementia | Why dementia incidence rates are declining | 09:33 min | View Session |
| P4-1 | T. Vos | Neuroepidemiology and Biomarkers of movement disorders | Global Burden of Neurological disorders | 11:08 min | View Session |
| P4-2 | M. Dichgans | Neuroepidemiology and Biomarkers of movement disorders | Updates on genetics in stroke risk | 10:13 min | View Session |
| P4-3 | C. Ketzoian | Neuroepidemiology and Biomarkers of movement disorders | Neuroepidemiology in Latin America | 09:41 min | View Session |
| P4-4 | Y. Béjot | Neuroepidemiology and Biomarkers of movement disorders | Impact of the ageing population on the contemporary profile of stroke patients: lessons from population-based registries | 08:33 min | View Session |
| P4-5 | B. Sabayan | Neuroepidemiology and Biomarkers of movement disorders | Heart-brain axis and brain health | 11:14 min | View Session |
| P4-6 | B. Miller | Neuroepidemiology and Biomarkers of movement disorders | Frontotemporal dementia | 18:48 min | View Session |
| P4-7 | H. Zetterberg | Neuroepidemiology and Biomarkers of movement disorders | Update on fluid biomarkers for Alzheimer's disease | 15:06 min | View Session |
| P5-1 | W. Carroll | Neurological care and rehabilitation (1) | Barriers to neurological care: Addressing the needs (keynote lecture) | 13:23 min | View Session |
| P5-2 | J. Bernhardt | Neurological care and rehabilitation (1) | Updates on post-stroke rehabilitation | 09:51 min | View Session |
| P5-3 | M. Alt Murphy | Neurological care and rehabilitation (1) | Predictors of stroke recovery | 07:47 min | View Session |
| P5-4 | A. Bonkhoff | Neurological care and rehabilitation (1) | Brain connectivity and recovery | 08:33 min | View Session |
| P5-5 | A. Thift | Neurological care and rehabilitation (1) | "They’ve got a bit better and they’re good enough to go back…” perspectives on stroke rehabilitation for aboriginal survivors | 07:36 min | View Session |
| P6-1 | W. Wang | Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders | Epidemiology of stroke in China (keynote lecture) | 12:47 min | View Session |
| P6-2 | P. Sachdev | Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders | The epidemiology of neurocognitive disorders from around the globe: findings from the COSMIC collaboration | 12:47 min | View Session |
| P6-3 | G. Deuschl | Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders | Changes in the epidemiology of neurological disorders in Europe | 11:14 min | View Session |
| P6-4 | T. Wijeratne | Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders | Increased global burden of headaches | 25:14 min | View Session |
| P6-5 | M. Hittle | Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders | Neurocoach - A Virtual Therapist for Post-Stroke Recovery | 09:50 min | View Session |
| P6-6 | M. Giroud | Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders | Psychosocial factors and stroke | 07:50 min | View Session |
| P6-7 | D. Cadilhac | Epidemiology of neurological disorders, Digital devices for and psycho-social factors in neurologic disorders | 10 years of the Australian Stroke Clinical Registry: How the data have been used to inform policy and practice? | 10:59 min | View Session |
| S1-1 | A. Gabet | Scientific Session #1 | Impact of the COVID-19 pandemic and a national lockdown on hospitalization for stroke and related 30-day mortality in France: a nationwide observational study | 14:32 min | View Session |
| S1-2 | A. Gabet | Scientific Session #1 | Characteristics, management and in-hospital mortality of patients hospitalized for stroke with a concomitant diagnostic of COVID-19 in France | 09:54 min | View Session |
| S1-3 | N. De Jong | Scientific Session #1 | White matter network structure as a substrate of cognitive brain reserve in cerebral small vessel disease: the maastricht study | 09:53 min | View Session |
| S1-4 | M. Vergonjeanne | Scientific Session #1 | Epidemiology of epilepsy in low- and middle-income countries: experience of a standardized questionnaire over the past two decades | 08:29 min | View Session |
| S1-5 | L. Duffner | Scientific Session #1 | Can engagement in socially and cognitively stimulating leisure activities compensate for other dementia risk factors? A prospective cohort study | 08:47 min | View Session |
| S2-1 | O. Filipets | Scientific Session #2 | Incidence of stroke in the urban area of western ukraine: temporal trends and features of statistical accounting | 11:03 min | View Session |
| S2-2 | R. S. Ragavan | Scientific Session #2 | Impact of varying look-back periods on estimating the number of person-based first-ever occurrences of strokes using linked hospitalisation data | 08:13 min | View Session |
| S2-3 | K. Robinson | Scientific Session #2 | Long-term risk of stroke in 123, 696 people with existing cardiac disease: a study using data linkage | 10:17 min | View Session |
| S2-4 | Z. Orman | Scientific Session #2 | Quality of life after stroke in a cluster randomized trial. Findings from standfirm | 07:23 min | View Session |
| S3-1 | T. Ullberg, K. Månsson | Scientific Session #3 | Structured multimodal follow-up after stroke: implementation aspects of a new paradigm | 11:11 min | View Session |
| S3-2 | M. Kilkenny | Scientific Session #3 | Australian Stroke Data Linkage Program: Using data to improve outcomes | 08:55 min | View Session |
| S3-3 | T. Green | Scientific Session #3 | Disorders of Consciousness (doc): Implications for nursing along the continuum | 26:06 min | View Session |
| S3-4 | N. Okubadejo | Scientific Session #3 | Utilizing disease registries to scale up neurology research in Africa: Experience from the Nigeria Parkinson Disease Registry | 09:17 min | View Session |
| S3-5 | M. Olaiya | Scientific Session #3 | Disparities by diabetes status in the quality of care and long-term outcomes following acute stroke or transient ischaemic attack | 07:14 min | View Session |
| S3-6 | S. Gall | Scientific Session #3 | Evaluating the effect of personalised knowledge to reduce the risk of stroke (PERKS-International) – study design protocol | 07:35 min | View Session |
| S4-1 | A. Eliakundu | Scientific Session #4 | Paramedic identification of stroke and associated access to reperfusion therapy: preliminary analysis of state linkage study | 07:59 min | View Session |
| S4-2 | A. Bonkhoff | Scientific Session #4 | Enhanced efficacy of acute intra-arterial recanalization therapies in female stroke patients | 09:37 min | View Session |
| S4-3 | E. Camerucci | Scientific Session #4 | Sex differences in deep brain stimulation implants, management and levodopa adjustments in two population-based parkinsonism cohorts in minnesota | 06:26 min | View Session |
| S4-4 | E. Camerucci | Scientific Session #4 | Incidence and Prevalence of Motor Fluctuations and Deep Brain Stimulation in Parkinson’s disease: A Comparison Between Two Population-based Cohorts in South East Minnesota | 07:19 min | View Session |
| S4-5 | A. Stang | Scientific Session #4 | Timeline, Incidence, Frequency and Survival of REM Sleep Behavior Disorder in Overt Alpha-Synucleinopathies | 06:36 min | View Session |
| S4-6 | E. Camerucci | Scientific Session #4 | Early-onset parkinsonism and early-onset parkinson’s disease: a population-based study (2010-2015) | 05:10 min | View Session |
| S5-1 | L. Harvey | Scientific Session #5: Neurological care and rehabilitation (2) | Spinal cord injury rehabilitation education on a global scale (keynote lecture) | 14:37 min | View Session |
| S5-2 | D. Gandhi | Scientific Session #5: Neurological care and rehabilitation (2) | Spinal cord injury rehabilitation education on a global scale (keynote lecture) | 16:21 min | View Session |
| S5-3 | J. Marshall | Scientific Session #5: Neurological care and rehabilitation (2) | Virtual reality in aphasia rehabilitation: Applications of EVA Park | 09:06 min | View Session |
| S5-4 | C. Riberholt | Scientific Session #5: Neurological care and rehabilitation (2) | Early rehabilitation approaches in severe acquired brain injury | 10:14 min | View Session |
| S6-1 | Y. Cao | Scientific Session #6 | Diet quality over middle adulthood and late-life subjective cognitive function among u.s. women | 07:18 min | View Session |
| S6-2 | R. S. Ragavan | Scientific Session #6 | Effect of varying look-back periods on estimating the trends in the incidence of stroke over time, using linked hospitalisation data | 07:05 min | View Session |
| S6-3 | X. Tian | Scientific Session #6 | Associations of hematological and biochemical markers with intracranial atherosclerosis: a systematic review and meta-analysis of observational studies | 08:41 min | View Session |
| S6-4 | J. Aked | Scientific Session #6 | Survival, Functional Status and Recurrence Three Years After First-Ever Stroke in Southern Sweden | 09:40 min | View Session |
| S6-5 | K. Dokova | Scientific Session #6 | Population-based stroke registry in varna, Bulgaria: feasibility and pilot data | 08:23 min | View Session |
| S6-6 | A. Avan | Scientific Session #6 | Stroke and dementia, leading causes of neurological disability and death, potential for prevention | 05:50 min | View Session |
| S6-7 | E. Pupillo | Scientific Session #6 | Early onset and increased risk of als in italian professional soccer teams | 07:44 min | View Session |
| S7-1 | S. Chopra | Scientific Session #7 | Neuropsychological Rehabilitation after Traumatic Brain Injury in Low-Resource Settings – A Single Blind Randomized Study | 12:50 min | View Session |
| S7-2 | R. M. Jose | Scientific Session #7 | Recurrent stroke in patients with atrial fibrillation: frequency and heterogeneity. | 05:56 min | View Session |
| S7-3 | D. Panov | Scientific Session #7 | Job stress and risk of stroke in population 25-64 years in Russia/Siberia: gender issues. MONICA-psychosocial epidemiological study | 06:42 min | View Session |
| S7-4 | A. Gbessemehlan | Scientific Session #7 | Association between depression, anxiety and dementia among older people in Central Africa: EPIDEMCA population-based study. | 06:48 min | View Session |
| S7-5 | S. Sardesai | Scientific Session #7 | Do dynamometric grip and pinch strengths correlate with upper limb capacity measured using action research arm test in stroke survivors? | 04:25 min | View Session |
| S7-6 | A. K. Malaha | Scientific Session #7 | Costs of dementia in low and middle income countries: a systematic review | 06:09 min | View Session |
| S8-1 | A. Wiśniewski | Scientific Session #8 | Validation of the National Institutes of Health Stroke Scale emphasizes its moderate psychometric properties | 09:55 min | View Session |
| S8-2 | S. A. Mioramalala | Scientific Session #8 | Availability and cost of antiepileptic and psychotropic drugs after community-based interventions in Madagascar | 07:09 min | View Session |
| S8-3 | L. Chen | Scientific Session #8 | Trends in clinical features and risk factors of amyotrophic lateral sclerosis: A 14-year cohort study in China | 07:06 min | View Session |
| S8-4 | X. Chen | Scientific Session #8 | Plasma Folate Levels in Relation to Cognitive Function: A community-based cohort of older adults in China | 06:31 min | View Session |
| S8-5 | M. Vergonjeanne | Scientific Session #8 | Instruments for investigation of epilepsy in low- and middle- income countries: a systematic review | 06:22 min | View Session |
| S8-6 | S.C.O. Martins | Scientific Session #8 | Adressing Lifestyle Modefication and Primary Prevention in a Continental Country | 08:41 min | View Session |
| S8-7 | A. Towfighi | Scientific Session #8 | Adressing Lifestyle for Stroke Prevention | 06:57 min | View Session |
| E | V. Feigin | Closing remarks, Best Abstract Award | Closing remarks, Best Abstract Award | 03:21 min | View Session |
| Eposter N. | Poster Titel | Main Author | Co-Authors | See the Poster |
|---|---|---|---|---|
| P1 | Feasibility of Dementia Assessments in the New Zealand (NZ) Indian Community | Rita Krishnamurthi | Adrian Martinez-Ruiz, Susan Yates, Ekta Singh Dahiya, Sanjalin Naiker, Reshmi Bala, Sarah Cullum, |  |
| P2 | A QUALITATIVE STUDY OF FACTORS AFFECTING TIME TO TREATMENT OF ANEURYSMAL SUBARACHNOID HAEMORRHAGE – THE REDDISH STUDY | Thuy Phuong Nguyen | C. Stirling, G. Kitsos, L. Nichols, R. Chandra, S. Rehman, K. Smith, I. Mosley, L. Lai, H. Asadi, J. Froelich, N. Thani, A. Thrift, S. Gall | |
| P3 | Comorbidities in patients with epilepsy: frequency, mechanisms and effects on long-term outcome | Giorgia Giussani | Elisa Bianchi MSc1*, Simone Beretta MD PhD2*, Davide Carone MD2*, Jacopo C DiFrancesco MD PhD2*, Andrea Stabile MD2, Clara Zanchi MD2, Marta Pirovano MD2, Claudia Trentini MD2, Giada Padovano MD2, Matteo Colombo MD2, Diletta Cereda MD2, Lorenzo Tinti MD2, Sofia Scanziani MD2, Sara Gasparini MD3, Graziella Bogliun MD2, Carlo Ferrarese MD PhD2, Ettore Beghi MD1*; for the PRO-LONG Study Group (#). | |
| P4 | Stroke Mortality Trend in Uruguay: A 60 years National Study | Stephanie Pino | Pino S, Rada D, Hackembruch H, Vázquez C, Ketzoina C, Gaye Saavedra A. | |
| P5 | Acute Triage of Pediatric Stroke in Eastern Denmark | Julie Bindslev | Klaus Hansen, Christina Hoei-Hansen, Thomas Truelsen | |
| P6 | Cerebral infarction in young adults. Analysis of 104 cases. | Otto Jesus Hernandez Fustes | M.S. Kawasaki, C. Arteaga Rodriguez | |
| P7 | Stroke subtypes in cancer patients and contributing risk factors in the stroke underlying mechanism, a retrospective study | lama almubarak | Farah Aleisa, MD, FRCPC, Hanouf Samadani, RN | |
| P8 | Excess Mortality in Stroke Patients Aged 80+ Years Receiving Acute Endovascular Recanalization Therapy, Eastern Denmark 2017-2019 | Nicolaj Grønbæk Laugesen | NG. Laugesen, K. Hansen, T. Stavngaard, J. Højgaard, T. Truelsen | |
| P9 | Electrode Optimization for Home-Based Health Monitoring EEG Acquisition | Theeban Shivaraja | Wan Asyraf Wan Zaid, Noorfazila Kamal, Kalaivani Chellappan | |
| P10 | Migraine: A Cross-sectional Study among Physicians and Medical Students Regarding Prevalence, Awareness and Knowledge of Diagnosis and Management | Hassan Choudry | F. Ata, M. Suheb, N. Alam | |
| P11 | A CLUSTER-RANDOMISED CONTROLLED TRIAL EVALUATING THE EFFECTIVENESS OF STROKE RISKOMETER IN IMPROVING STROKE RISK AWARENESS IN ADULTS: A PRELIMINARY STUDY | Mohamad Zarudin Mat Said | Zarudin MS, Kamarul Imran Musa, T.Alina T.Ismail, Anees AH, Ramesh Sahathevan, Zariah AA, Valery Feigin | |
| P12 | Validation of the Lebanese Arabic version of the BACS scale (the Brief Assessment of Cognition in Schizophrenia) among schizophrenic inpatients | Chadia Haddad | Chadia Haddad, P. Salameh, S. Hallit, S. Obeid, G. Haddad, JP. Clément, B. Calvet | |
| P13 | Pontine Infarct with uncrossed Hemiparesis . A case report | Ahmed ZAMIR | Dr Naveed Alam | |
| P14 | STROKE INCIDENCE IN SARS-COVID EPIDEMICS: THE EXPERIENCE OF ODESSA | Yurii Vorokhta | Muratova T., Khramtsov D., Stoyanov A., Zbrozhek S., Voronina R., Khubetova I., Vikarenko M., Kozlova G., Dobush I., Andryuschenko E. | |
| P15 | Epidemiology of Parkinson disease in Odessa (2017-2019) | Yurii Vorokhta | I. Khubetova | |
| P16 | Evaluating the potential of mobile phone-based applications in improving stroke awareness among the Auckland Population | navneet kaur | | |
| P17 | Population-based validation of prehospital stroke scales for the detection of large vessel occlusion : Dijon Stroke Registry | Gauthier Duloquin | G. Duloquin, M. Graber, L. Garnier, V. Crespy, M. Giroud, Y. Bejot | |
| P19 | INCIDENCE AND CSF BIOMARKERS PATTERN IN FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) IN THE SALENTO AREA PUGLIA | Chiara Zecca | Chiara Zecca, Maria Teresa Dell’Abate, Miriam Accogli, Rosa Capozzo, Maria Rosaria Barulli, Maria Elisa Frisullo, Giancarlo Logroscino | |
| P20 | ASSOCIATION OF ANKLE-BRACHIAL INDEX WITH ISCHEMIC STROKE OUTCOME IN DIABETIC PATIENTS: A CASE-CONTROL STUDY | Fakhrur Razy | Fakhrurrazy, S. Manurung, A. Yuwono, H. Khatimah | |
| P21 | Synergies TO Prevent stroke – STOPstroke – an interdisciplinary research program on stroke prevention | Seana Gall | Amanda Thrift, Judith Katzenellenbogen, Mark Nelson, Timothy Kleinig, Valery Feigin, Dominique Cadilhac, Lee Nedkoff, Joosup Kim, Monique Kilkenny | |
| P23 | Incidence and Prevalence of Stroke and its Risk Factors in the Philippines: A Systematic Review | Maria Epifania Collantes | Zuniga YH, Uezono DR | |
| P24 | LOW VERSUS STANDARD DOSE OF INTRAVENOUS THROMBOLYSIS WITH ALTEPLASE IN ISCHEMIC STROKE PATIENTS OLDER THAN 80 YEARS OLD: AN OBSERVATIONAL STUDY | Laura Baptiste | S. Olindon, I. Sibon, Y. Béjot | |
| P25 | Paradoxical effect of smoking on motor progression and dopaminergic putaminal denervation in Parkinson’s disease. | Daniele Urso | B. Tafuri, S. Nigro, G. Logroscino | |
| P26 | Reduction in Acute Stroke Admissions During the COVID-19 Pandemic – Data from the Israeli National Stroke Registry | Inbar Zucker | A. Ram, Y. Hershkovitz, D. Tanne, N. M. Bornstein, R. R. Leker, A. Horev, H. Hallevi, S. Peretz, D. Orion, I. Zucker | |
| P27 | Synergies TO Prevent stroke – STOPstroke – an interdisciplinary research program on stroke prevention | Seana Gall | Amanda Thrift, Judith Katzenellenbogen, Mark Nelson, Timothy Kleinig, Valery Feigin, Dominique Cadilhac, Lee Nedkoff, Joosup Kim, Monique Kilkenny | |
| P28 | Application of motor learning principles in upper limb task-oriented training in stroke clinical trials – A scoping review | Subramanian Durairaj | Sanjukta Sardesai, Dr. Mindy F. Levin, Dr. John M. Solomon | |
[pdfjs-viewer url=”https://access.ianeneurology.org/download/day2.pdf” viewer_width=100% viewer_height=800px fullscreen=true download=true print=true]
[pdfjs-viewer url=”https://access.ianeneurology.org/download/day1.pdf” viewer_width=100% viewer_height=800px fullscreen=true download=true print=true]
[pdfjs-viewer url=”https%3A%2F%2Faccess.ianeneurology.org%2Fwp-content%2Fuploads%2F2021%2F01%2Ftelemed_Terms-of-Use_V1.pdf” viewer_width=100% viewer_height=800px fullscreen=true download=true print=true]
Concept
Mobility has become one of the key issues in society today. Environmental problems and pandemic effects lead to changes in transportation, the quality of life in urban communities, and the development of urban clusters. At the same time, the ageing challenge triggers a profound impact on the social fabric of cities.
By 2030 all major urban centres in the OECD will see a sharp increase in the number of elderly – the share of aged 60 and above will grow from 30% to 39%. For the first time in history, the elderly will be the largest age group by 2045.
The global ageing of urban populations calls for more age-friendly approaches to be implemented. Cities will need to adapt and develop a number of short and longer-term strategies, integrating assistive technologies, to ensure they respond adequately to both the challenges and opportunities that an ageing population present.
All these challenges affect government and community engagement, and additionally the huge universe of R&D, innovation, business and corporate solutions linked to it.
| Number 1 | Title | Action |
|---|---|---|
| 1 | What us UMSA about ? | |
| 2 | Blog UMSA |
| Number 1 | Title | Action |
|---|---|---|
| 1 | What us UMSA about ? | |
| 2 | Blog UMSA |
European Menopause and Andropause Socety
Rue du Rhone, 118
CH-1204 Geneva
Phone: +41 22 510 1278
Email: info@emas-online.org
| Sr.no | Title | Action |
|---|---|---|
| 1 | Company Video | |
| 2 |
[evp_embed_video url="https://vimeo.com/272444763" autoplay="true"]| Video | Slido |
|---|---|
https://access.ianeneurology.org/wp-content/uploads/2020/08/Copy-of-Copy-of-Copy-of-pan-arb-2.png https://streaming.salesbridges.com:5443/LiveApp/streams/669185674250831530552500.m3u8 |
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.
Physician and medical doctor from the University of Cadiz. Medical oncologist at the Clinical University Hospital of Valencia and Biomedical Research institute INCLIVA
Associate Professor of Medicine School at University of Valencia
She develops her assistance and research work in the breast pathology unit. She has an extensive experience in clinical trials and research projects in the area of breast cancer.Member of the breast cancer research group at the Carlos III institute.Member of the board of GEICAM (Spanish Breast Cancer Research Group)
Dr. Enrique Santas, MD, PhD, is a cardiologist at the Hospital Clínico Universitario in Valencia (Spain). He is an active clinician and an emergent researcher, with a focus on heart failure and cardiac imaging. Currently, he is the director of the cardio-oncology program at his institution, dedicated to the cardiovascular health of patients undergoing cancer treatment as well as cancer survivors.